Compare CSBR & IDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CSBR | IDE |
|---|---|---|
| Founded | 1985 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 90.0M | 177.6M |
| IPO Year | 1986 | N/A |
| Metric | CSBR | IDE |
|---|---|---|
| Price | $7.33 | $12.34 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | 21.7K | ★ 33.5K |
| Earning Date | 12-15-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.83% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.17 | N/A |
| Revenue | ★ $58,424,000.00 | N/A |
| Revenue This Year | $7.31 | N/A |
| Revenue Next Year | $12.01 | N/A |
| P/E Ratio | $40.51 | ★ N/A |
| Revenue Growth | ★ 9.06 | N/A |
| 52 Week Low | $5.59 | $8.61 |
| 52 Week High | $11.99 | $10.46 |
| Indicator | CSBR | IDE |
|---|---|---|
| Relative Strength Index (RSI) | 54.60 | 68.26 |
| Support Level | $6.74 | $12.05 |
| Resistance Level | $7.39 | $12.10 |
| Average True Range (ATR) | 0.57 | 0.11 |
| MACD | 0.08 | 0.05 |
| Stochastic Oscillator | 44.50 | 97.92 |
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
Voya Infrastructure, Industrials and Materials Fund is a diversified closed-end management investment company. The primary objective of this investment fund is to achieve total return by combining current income, capital gains, and capital appreciation. To achieve this objective, the fund invests in companies that own and/or operate infrastructure facilities in the infrastructure sector, as well as in a broad range of companies in the industrials and materials sectors that the Sub-Adviser believes will benefit from infrastructure building, renovation, expansion, and utilization.